The clinical utility of blood-based biomarkers of Alzheimer’s disease: Triumphs and pitfalls

Mohammad Muzaffar Mir, Gulzar Muzaffar Mir, Abdul Majid, Muffarah Hamid Alharthi, Abdullah M. Alshahrani

Open source

DOI
10.1016/bs.irn.2026.05.008
Published
2026
Container
International Review of Neurobiology
Publisher
Elsevier
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/bs.irn.2026.05.008,
  title = {The clinical utility of blood-based biomarkers of Alzheimer’s disease: Triumphs and pitfalls},
  author = {Mohammad Muzaffar Mir and Gulzar Muzaffar Mir and Abdul Majid and Muffarah Hamid Alharthi and Abdullah M. Alshahrani},
  year = {2026},
  journal = {International Review of Neurobiology},
  doi = {10.1016/bs.irn.2026.05.008},
  url = {https://doi.org/10.1016/bs.irn.2026.05.008}
}

RIS

TY  - JOUR
TI  - The clinical utility of blood-based biomarkers of Alzheimer’s disease: Triumphs and pitfalls
AU  - Mohammad Muzaffar Mir
AU  - Gulzar Muzaffar Mir
AU  - Abdul Majid
AU  - Muffarah Hamid Alharthi
AU  - Abdullah M. Alshahrani
PY  - 2026
JO  - International Review of Neurobiology
DO  - 10.1016/bs.irn.2026.05.008
UR  - https://doi.org/10.1016/bs.irn.2026.05.008
ER  - 

APA

Mir, M. M., Mir, G. M., Majid, A., Alharthi, M. H., & Alshahrani, A. M. (2026). The clinical utility of blood-based biomarkers of Alzheimer’s disease: Triumphs and pitfalls. International Review of Neurobiology. https://doi.org/10.1016/bs.irn.2026.05.008

Source records